臺北醫學大學新藥開發研究中心

Medicine & Life Sciences

1. Histone Deacetylase Inhibitors 100%
2. Neoplasms 74%
3. Histone Deacetylases 59%
4. Mucocutaneous Lymph Node Syndrome 50%
5. Apoptosis 50%
6. Inhibitory Concentration 50 44%
7. Growth 41%
8. Taiwan 41%
9. Colorectal Neoplasms 37%
10. In Vitro Techniques 37%
11. Antineoplastic Agents 37%
12. Proteins 37%
13. Tubulin 37%
14. Tubulin Modulators 33%
15. Glioblastoma 30%
16. Microtubules 29%
17. denbinobin 28%
18. osthol 28%
19. Therapeutics 28%
20. Phosphorylation 27%
21. Heterografts 27%
22. Genes 27%
23. Down-Regulation 26%
24. Pharmaceutical Preparations 26%
25. Cell Line 26%
26. Breast Neoplasms 25%
27. Non-Small Cell Lung Carcinoma 25%
28. Cell Movement 25%
29. Population 25%
30. hispidulin 24%
31. Lung Neoplasms 23%
32. Autophagy 22%
33. Temozolomide 22%
34. Single Nucleotide Polymorphism 22%
35. Histone Deacetylase 6 22%
36. Gene Expression 21%
37. Acetylation 20%
38. Cell Death 20%
39. indoline 20%
40. Reactive Oxygen Species 19%
41. 3-(1-benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide 19%
42. Vorinostat 19%
43. Intravenous Immunoglobulins 19%
44. Hydroxamic Acids 18%
45. Stromal Interaction Molecule 1 18%
46. Aryl Hydrocarbon Receptors 18%
47. Glioma 18%
48. Triple Negative Breast Neoplasms 17%
49. Neoplasm Metastasis 17%
50. Hypoxia-Inducible Factor 1 17%
51. Cyclooxygenase 2 17%
52. Nanoparticles 16%
53. Cell Proliferation 16%
54. Up-Regulation 16%
55. Ankylosing Spondylitis 16%
56. 3,6-bis(5-chloro-2-piperidyl)-2,5-piperazinedione 16%
57. Human Umbilical Vein Endothelial Cells 15%
58. Histones 15%
59. quinoline 15%
60. Western Blotting 14%
61. Messenger RNA 14%
62. Calcium 14%
63. Antimitotic Agents 14%
64. MPT0B098 14%
65. MPT0L145 14%
66. WMJ-S-001 13%
67. Lipopolysaccharides 13%
68. fosbretabulin 13%
69. DNA Damage 13%
70. Protein Isoforms 13%
71. Polymerization 13%
72. HSP90 Heat-Shock Proteins 12%
73. A549 Cells 12%
74. Cohort Studies 12%
75. Acute Myeloid Leukemia 12%
76. Benzamides 12%
77. Phosphatidylinositol 3-Kinases 12%
78. Transforming Growth Factors 12%
79. Caspase 3 12%
80. shikonin 12%
81. ErbB Receptors 12%
82. Anti-Inflammatory Agents 12%
83. Pharmaceutical Chemistry 12%
84. Antibodies 12%
85. Binding Sites 12%
86. Cell Cycle Checkpoints 12%
87. Colchicine 11%
88. Prostatic Neoplasms 11%
89. Phosphotransferases 11%
90. Human Activities 11%
91. Coronary Vessels 11%
92. Genetic Polymorphisms 11%
93. DNA 11%
94. Blood Vessels 11%
95. Cisplatin 11%
96. Inflammation 11%
97. Smooth Muscle Myocytes 11%
98. indole 11%

Chemical Compounds

1. Histone 67%
2. Protein 49%
3. Antiproliferative 36%
4. Antineoplastic Agent 30%
5. Drug 28%
6. Hydroxamic Acid 22%
7. Antitumor 21%
8. Reactive Oxygen Metabolite 20%
9. Genetic Polymorphism 20%
10. Apoptotic 18%
11. Cell Death 15%
12. Osthole 15%
13. Temozolomide 15%
14. Resistance 15%
15. 50 Percent Growth Inhibition 15%
16. Colchicine 14%
17. Retinal 14%
18. Metabolite 14%
19. Polymerization Reaction 13%
20. Hispidulin 12%
21. Acetylation 12%
22. Genotoxicity 12%
23. Bioavailability 11%
24. Antioxidant Agent 10%
25. Pharmacokinetics 10%
26. Vascular Targeting Agent 10%
27. Structure-Activity Relationship 9%
28. Western Blotting 9%
29. Binding Site 9%
30. Glycol 9%
31. Calcium(0) 9%
32. Phosphotransferase Inhibitor 9%
33. Shikonin 9%
34. Retinal Pigment 9%
35. Disorder 8%
36. Lipopolysaccharide 8%
37. Cell Viability 8%
38. Membrane Potential 8%
39. Pharmacological Metabolism 8%
40. Modification 8%
41. Flavonoid 8%
42. Vorinostat 8%
43. Marker 8%
44. Dose 8%
45. Hydrocarbon 8%
46. Antigen 8%
47. Bioactivity 7%
48. Cleavage 7%
49. Total Synthesis 7%
50. Molecule 7%
51. Occurrence in Nature 7%
52. Anilide 7%
53. Oxidative Stress 7%
54. Protective 7%
55. Flow 7%
56. Weight 7%
57. Biological Marker 6%
58. Chidamide 6%
59. Superoxide 6%
60. Alkannin 6%
61. Heat 6%
62. Antiinflammatory 6%
63. Tyrosine 6%
64. Antimitotic Agent 6%
65. Poly(ethylene Glycol) 6%
66. Glucose 6%
67. Drug Target 6%
68. Metabolic 6%
69. Indoline 6%
70. Chemistry 6%
71. Substitution Reaction 5%
72. EC 2.7.12.2 (Mitogen-Activated Protein Kinase Kinase) Inhibitor 5%
73. Application 5%
74. Growth Inhibition 5%
75. Genotoxic 5%
76. Antimitotic 5%
77. Chemoattractant 5%
78. Microtubule-Destabilising Agent 5%
79. Nanoparticle 5%
80. Clearance 5%
81. Enzyme Activity 5%
82. Antivascular 5%
83. Messenger RNA 5%
84. Aporphine 5%
85. Plasma 5%
86. Benzamide 5%
87. MicroRNA 5%
88. Antidiabetic Agent 5%
89. Zinc Oxide Nanoparticle 5%